Results
3B BlackBio Dx FY26 Revenue ₹142cr PAT ₹60cr
3B BlackBio reported consolidated FY26 revenue of ₹142 crores with PAT of ₹60 crores, driven by 10% growth in domestic molecular diagnostics and strong contributions from TRUPCR Europe and Coris BioCo
